Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  karenitecin
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-7 of 7 for your search:
Start Over
Karenitecin Versus Topotecan in Patients With Advanced Epithelial Ovarian Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: KTN32313R, NCT00477282
Karenitecin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000068456, U10CA031946, CLB-30004, CALGB-30004, NCT00010218
Karenitecin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: Any age
Sponsor: NCI, Other
Protocol IDs: GOG-0186D, NCI-2012-02514, CDR0000269898, BIONUM-KTN22307, U10CA027469, NCT00054119
Study of Karenitecin (BNP1350) in Patients With Brain Tumors
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: KTN20405, NCT00062478
Phase I Study of Karenitecin in Patients With Recurrent Malignant Glioma
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NABTT-2006, JHOC-NABTT-2006, NCT00014521
Trial of Oral Karenitecin in Patients With Solid Tumors and Lung Cancer
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: KTN22208, NCT00097903
Karenitecin in Pediatric Patients With Refractory or Recurrent Solid Tumors N10010)
Phase: Phase I
Type: Treatment
Status: Completed
Age: 1 to 21
Sponsor: Other
Protocol IDs: H-20159, KTN10010, BMP1350, NCT00586560
Start Over